LINC01535: A Non-Protein-Coding RNA Molecule with Potential as a Drug Target or Biomarker

Target Name: LINC01535

NCBI ID: G101927667

LINC01535

Other Name(s): Long intergenic non-protein coding RNA 1535, transcript variant 1 | long intergenic non-protein coding RNA 1535

LINC01535: A Non-Protein-Coding RNA Molecule with Potential as a Drug Target or Biomarker

LINC01535 is a non-protein coding RNA (ncRNA) molecule located in chromosome 6p21.1. It is characterized by its unique 5'-end, which is different from the typical 3'-end found in mostncRNAs. LINC01535 has a length of 292 nucleotides and an estimated translation efficiency of 0.47.

The LINC01535 gene has been implicated in various cellular processes, including cell adhesion, migration, and invasion. It has also been associated with various diseases, including cancer and neurodegenerative diseases.

Recent studies have suggested that LINC01535 may be a potential drug target or biomarker. One reason for this is its unique structure, which may allow for the development of specific small molecules that interact with specific regions of the LINC01535 molecule. Additionally, the gene has been shown to be expressed in various tissues and cells, which may make it a useful target for drug development.

Another potential mechanism by which LINC01535 may be targeted is its role in cell adhesion. LINC01535 has been shown to be involved in the formation of tight junctions, which are a type of cell-cell adhesion structure. This suggests that LINC01535 may be a useful target for drugs that are designed to disrupt cell-cell adhesion.

In addition to its potential role in cell adhesion, LINC01535 has also been associated with the development of various diseases. For example, studies have shown that LINC01535 is overexpressed in various neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This suggests that LINC01535 may be a useful biomarker for these diseases and may also be a potential drug target.

Another potential mechanism by which LINC01535 may be targeted is its role in cancer progression. LINC01535 has been shown to be involved in the regulation of cell proliferation and has been implicated in the development of various types of cancer. This suggests that LINC01535 may be a useful target for drugs that are designed to inhibit cell proliferation or prevent cancer from progressing.

In conclusion, LINC01535 is a unique and promising non-protein coding RNA molecule that has the potential to be a drug target or biomarker. Its unique structure and its involvement in various cellular processes make it an attractive target for small molecules that can interact with specific regions of the LINC01535 molecule. Additionally, its association with various diseases and its potential role in cell adhesion, cancer progression, and neurodegenerative diseases make it a promising target for drug development. Further research is needed to fully understand the potential mechanisms by which LINC01535 interacts with the cell and to develop effective drugs that can target it.

Protein Name: Long Intergenic Non-protein Coding RNA 1535

The "LINC01535 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01535 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets